Spray Drying for Inhaled Drugs: Minimize Risk, Maximize Yield
Abstract: Late-stage scaling of spray drying for inhaled formulations can result in avoidable delays, post-approval issues, and cost overruns. This infographic shows how proactive CMC planning, paired with the right spray dryer size, sets you up for success. It helps reduce risk, improve yield, and ensure readiness for commercial scale-up.
Catalent Boston supports scalable spray drying across all development stages: clinical, pilot, and commercial. The site offers seamless integration from powder manufacturing to blister packaging.
Download this infographic to make smarter scale and equipment decisions, and accelerate commercialization.